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Ⅰ． Mast cells as the major effector cells of 
the type I hypersensitivity reactions.
 Mast cells are recognized as the major effector cells 
of the type I hypersensitivity reactions because of their 
high-affinity receptors for IgE （FcɛRI）. They are known 
to play a pivotal role in allergic diseases, such as atopic 
rhinitis, asthma, and atopic dermatitis. Engagement of 
FcɛRI by IgE, followed by the aggregation of multiple 
IgE-bearing FcɛRI molecules by polyvalent antigen, 
leads to degranulation, and release of histamine, LTC4 
and other preformed chemical mediators. Additionally 
multiple cytokine genes are transcribed, newly 
synthesized arachidonic acid metabolites are secreted, 
all of which trigger allergic inflammation. Though it is 
well established that mast cells mediate the early phase 
of type I hypersensitivity reactions by releasing granule 
contents after FcɛRI crosslinking, the precise regulatory 
mechanisms that lead to IgE-dependent exocytosis in 
mast cells have been unknown. 
Ⅱ． SNARE proteins play a central regulatory 
role in exocytosis.
 SNARE （soluble N-ethylmaleimide-sensitive 
fusion factor attachment protein receptor） proteins play 
a central regulatory role in exocytosis by promoting 
vesicle fusion with the plasma membrane［1］. The 
association of v-SNAREs and t-SNAREs to form a 
ternary SNARE complex that catalyses membrane fusion 
is required for exocytotic processes in many cells （Fig. 
1）. The SNARE complex brings the two membranes in 
apposition, a necessary step in overcoming the energy 
barrier required for membrane fusion. In mast cells, 
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SUMMARY
Mast cells are known to play a pivotal role in allergic diseases such as allergic rhinitis, asthma, 
and atopic dermatitis by releasing granules containing histamine, LTC4, and other preformed chemical 
mediators.  However, the precise regulatory mechanisms that lead to IgE-dependent exocytosis in mast 
cells have been unknown. Recently, I have shown that IKK2 （also called IKKβ）, a catalytic subunit 
of the IKK complex and a central component of the intracellular signaling pathway mediating NF-κB 
activation, induces IgE-mediated degranulation in mast cells by phosphorylating SNAP-23, the target 
membrane soluble N-ethylmaleimide-sensitive fusion factor attachment protein receptor （SNARE）. 
This review highlights the molecular mechanisms of IKK2-mediated degranulation in mast cells and 
provides a novel potential therapeutic approach for allergic diseases.
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these include syntaxin 4 and SNAP-23 as t-SNAREs, 
while VAMP-2 and VAMP-8 represent candidates for 
v-SNAREs. The syntaxin-binding protein Munc18b 
and Munc18c are also essential for exocytosis in mast 
cells. It has been shown that phosphorylation of SNAP-
23 modulates exocytosis［2］. Though protein kinase C 
can phosphorylate SNAP-23 in vitro, it has not been 
established as to which kinase phosphorylates SNAP-23 
in vivo and regulates exocytosis in mast cells［2］.
Ⅲ． IKK2 is a central component of the 
intracellular signaling pathway mediating 
NF-κB activation.
 Transcription factors of nuclear factor-κB （NF-κB） 
is one of the major signaling pathways activated when 
cells are exposed to a variety of stimuli, including 
cytokines, such as TNF and IL-1, ultraviolet （UV） 
radiation, stress, and assaults. Upon activation, NF-κB 
regulate hundreds of genes in the context of multiple 
important biological processes, such as apoptosis, 
proliferation, innate and adaptive immune responses, 
and inflammation. The IKK-complex coordinates the 
response to most of the external signals leading to the 
induction of NF-κB activated gene transcription. The 
activity of the IKK-complex resides in two catalytic 
subunits, IKK1 （also called IKK α） and IKK2 （also 
called IKK β）, and two regulatory subunits, NEMO 
and ELKs. Interestingly IKK2 is the major cytokine-
responsive IκB kinase and thus is a central component 
of the intracellular signaling pathway mediating 
NF-κB activation. IKK2 shares sequence and structural 
similarity with IKK1 （50% sequence identity）. The 
crystal structure analysis of IKK2 in the IKK complex 
reveals a trimodular architecture comprising the kinase 
domain, a ubiquitin-like domain, and an elongated, 
α-helical scaffold/dimerization domain. The ubiquitin-
like domain and scaffold/dimerization domain mediate 
a critical interaction with IκBα that restricts substrate 
specificity. The ubiquitin-like domain is also required 
for catalytic activity of IKK2. The scaffold/dimerization 
domain mediates IKK2 dimerization that is required for 
IKK2 activation. IKK2 is responsible for the majority 
of IKK activity in most cell types. Consequently, IKK2-
deficient cells or mice exhibit less phosphorylation 
of IκBα, resulting in defective NF-κB activation. 
In addition to NF-κB-dependent functions of IKK2, 
accumulated evidences suggest that IKK2 regulates 
some biological phenomenon in a NF-κB-independent 
manner. 
Ⅳ． Critical roles of IKK2 in mast cell 
degranulation.
 Roles of IKK2  and/or NF-kBs in mast cell-
mediated allergic reactions have been undetermined. 
Recently, I have shown that IKK2 induces IgE-mediated 
degranulation in mast cells by phosphorylating SNAP-
23, the target membrane soluble N-ethylmaleimide-
sensitive fusion factor attachment protein receptor 
（SNARE）, and that this novel IKK2-mediated function 
is completely NF-κB-independent［3］.
ａ） IKK2 in mast cells plays important roles in 
anaphylactic responses in vivo.
 To investigate the role of IKK2 on anaphylactic 
responses, which is induced by mast cells, I used mast 
cell knock-in mouse model［4］. Fetal liver-derived mast 
Fig. 1 SNARE pin formation is required for exocytotic 
process.
　The association of v-SNAREs on the vesicle membrane 
and t-SNAREs on the plasma membrane to form a ternary 
SNARE complex that catalyses membrane fusion is 
required for exocytotic processes in many cells. In mast 
cells, the exocytotic processes is called “degranulation”.
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cells （FLMCs） were generated from days 11.5-12.5 
embryonic liver of wild type （WT） or IKK2-deficient 
（IKK2-/-） mice because of the lethality in the IKK2-/- 
embryos at E14［5］. To generate mast cell knock-in 
mice, cultured FLMCs were transplanted intradermally 
（i.d.） or intravenously （i.v.） into mast cell-deficient 
WBB6F1-Kitw/Kitw-v （W/Wv） mice. Four weeks 
after transplantation, IgE-dependent anaphylactic 
reactions in mast cell-reconstituted mice were examined. 
As shown in Figure 2, antigen challenge of mice that 
had been sensitized previously with monoclonal DNP-
specific IgE antibody demonstrated that IKK2-/- 
FLMCs reconstituted mice exhibited reduced cutaneous 
anaphylaxis than the WT FLMCs reconstituted mice, 
as assessed by change in ear. I next examined passive 
systemic anaphylaxis by measuring decrease of body 
temperature after antigen challenge. Figure 3 shows 
a decrease in passive systemic anaphylaxis in the 
IKK2-/- FLMCs reconstituted mice. These data imply 
a physiological role of IKK2 in mast cells is to induce 
appropriate mast cell degranulation.
ｂ） IKK2 induces mast cell degranulation in a 
kinase activity-dependent manner.
 To investigate the cellular basis for the diminished 
in vivo anaphylactic reactions in IKK2-/- FLMCs 
reconstituted mice, I next compared degranulation 
（release of β-hexosaminidase and histamine which 
distribute in mast cell granule at steady state） between 
FLMCs derived from WT and IKK2-/- mice. Consistent 
with the defect in anaphylactic responses in vivo, 
IKK2-/- FLMCs showed clear defects in FcɛRI-
stimulated β-hexosaminidase release （Fig. 4A）, and 
Fig. 2 Severe impairment of passive cutaneous ana-
phylaxis in the absence of IKK2.
　For passive cutaneous anaphylaxis （PCA）, WT or 
IKK2-/- mast cells were injected intradermally into the 
right ear of W/Wv mice. Four weeks later, mice were 
first primed with antigen-specific IgE by intradermal 
injection twenty-four hours later, the mice were injected 
with antigen. The degree of PCA was estimated by 
quantification of ear swelling. P＜0.01. （ref.3）
Fig. 3 Severe impairment of systemic anaphylaxis in 
the absence of IKK2.
　For systemic anaphylaxis, we injected WT or IKK2-/- 
mast cells, into W/Wv mice to elicit systemic anaphylactic 
reactions. Four weeks later, mice were primed with 
antigen-specific IgE by i.v. injection. After another 
twenty-four hours, mice were injected with antigen and 
the systemic anaphylactic response was monitored by 
measuring rectal temperature. *P＜0.01. （ref.3）
Fig. 4 IKK2 plays critical roles in mast cell degranula-
tion.
　（A） IgE-induced β-hexosaminidase release is 
impaired in IKK2-/- mast cells. WT or IKK2-/- mast 
cells were cross-linked upon FcɛRI. Thirty minutes later, 
β-hexosaminidase activity in the supernatants and lysate 
of the cell pelletes was quantified. *P＜0.01. （B） IgE-
induced histamine release is impaired in IKK2-/- mast 
cells. WT or IKK2-/- mast cells were cross-linked upon 
FcɛRI. Thirty minutes later, cell-free supernatants were 
recovered. Histamine was measured by EIA. *P＜0.01. 
（ref.3）
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%histamine release （Fig. 4B）. I also examined the effect 
of over-expression of IKK2 in the mast cells on FcɛRI-
stimulated β-hexosaminidase release. RBL-2H3, a rat 
basophilic cell line stably expressing GFP-IKK2 resulted 
in the increase of FcɛRI-stimulated β-hexosaminidase 
release （Fig. 5）. To determine whether kinase activity 
of IKK2 is required for IKK2-mediated up-regulation 
of FcɛRI-stimulated β-hexosaminidase release, the 
effect of over-expression of IKK2KM, a kinase inactive 
mutant of IKK2, on FcɛRI-stimulated β-hexosaminidase 
release was examined. Over-expression of IKK2KM did 
not enhance FcɛRI-stimulated β-hexosaminidase release 
（Fig. 5）. These results suggest that IKK2 modulates 
antigen-induced mast cell degranulation in a kinase 
activity-dependent manner.
ｃ） NF-κB activation is not essential for mast cell 
degranulation.
 The seminal event in NF-κB activation is the 
phosphorylation of IκBs, which is mediated by IKK 
complex. Therefore, the role of NF-κB activation 
in FcɛRI-induced degranulation was examined. 
NF-κB activation and IgE-induced degranulation were 
examined in RBL-2H3 cells stably expressing IκBα 
superrepressor （IκBαM）. As expected, expression of 
IκBαM in the RBL-2H3 cells resulted in the complete 
inhibition of NF-κB-dependent promoter activation 
in response to TNF alpha （Fig. 6A）. In contrast, 
IκBαM-expressing RBL-2H3 cells showed similar 
levels of FcɛRI-stimulated β-hexosaminidase release 
to the control cells. （Fig. 6B）. It thus appears that 
FcɛRI-induced degranulation is independent of NF-κB 
activation pathway. I thus conclude that IKK2 modulates 
IgE-induced degranulation by NF-κB-independent 
mechanism.
ｄ） IKK2 is recruited to the lipid rafts upon FcɛRI 
stimulation and associates with SNAP-23.
 Mast cells contain the molecular machinery that 
drives membrane fusion during granule exocytosis. 
Essential to this process are SNARE ［soluble NSF 
（N-ehyl-maleimide-sensitive factor） attachment 
protein receptor］ proteins that lie on opposing cellular 
membranes to form a stable multimeric complex that 
catalyze fusion［1］. Mast cells express several plasma 
membrane-localized SNAREs （Q-SNAREs） that form 
part of the exocytotic machinery. Both SNAP-23 and 
syntaxin 4 have been implicated in IgE-dependent 
fusion and are partly localized in lipid rafts, domains 
Fig. 5 Over-expression of IKK2 results in increase of 
degranulation. 
　RBL-2H3 cells （basophil line） were transfected 
with pcDNA3.1/Zeo GFP-IKK2, pcDNA3.1/Zeo GFP-
IKK2KM, and pcDNA3.1/Zeo GFP vector （as control）. 
Cells were cross-linked upon FcɛRI. Thirty minutes later, 
β-hexosaminidase activity in the supernatants and lysate 
of the cell pelletes was quantified. *P ＜0.01. NS, not 
significant. （ref.3）
Fig. 6 NF-κB activation is not essential for mast cell 
degranulation.
　（A） RBL-2H3 cells were transfected with pcDNA3.1/
Zeo IκBαM （dominant negative mutantof IkBα） and 
pcDNA3.1/Zeo mock vector （as control）. Cells were 
transfected with HIV-3x-κB luciferase and β-galactosidase 
plasmid. 24 hours later, cells were stimulated with （black 
columns） or without （white columns） TNF-α. 6 hours 
later, luciferase activity was measured. *P ＜0.01. （B） 
Cells were cross-linked upon FceRI. Thirty minutes later, 
β-hexosaminidase activity in the supernatants and lysate 
of the cell pelletes was quantified. （ref.3） 
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rafts after FcɛRI-stimulation. SNAP-23 and syntaxin 4 
were detected in the membrane raft fraction before and 
after FcɛRI stimulation （Fig. 7, co-sedimentation with 
CTx in fraction 5）. Little or no IKK2 was detected in 
the lipid rafts. In contrast, substantially increased levels 
of IKK2 were detected in the membrane raft fraction 
upon FcɛRI stimulation （Fig. 7）, suggesting that IKK2 
co-localize with SNAP-23 and syntaxin 4 in the lipid 
rafts only after stimulation. Furthermore, I examined 
whether IKK2 associates with SNAP-23 in the lipid 
rafts before/after FcɛRI-stimulation. IKK2 and SNAP-
23 co-immunoprecipitated in the raft fractions following 
FcɛRI-stimulation （Fig. 8）. These results suggest that 
IKK2 associates with SNAP-23 in the lipid rafts only 
after FcɛRI-stimulation.
ｅ） IKK2 phosphorylates SNAP-23 on Ser120 and 
Ser95.
 Phosphorylation of SNAP-23 on Ser120 and Ser95 
modulates regulated exocytosis by mast cells［2］. I 
hypothesized that SNAP-23 is a substrate for IKK2. In 
vitro kinase assays showed that IKK2 phosphorylated 
SNAP-23 （Fig. 9A）. However, when Ser120, Ser95, 
or both of them were converted to Ala, phosphorylation 
of recombinant mutant SNAP-23  by IKK2  was 
substantially attenuated （Fig. 9A）, indicating that IKK2 
can phosphorylate SNAP-23 at both Ser120 and Ser95 
of the plasma membrane enriched in sphingolipids, and 
cholesterol. Furthermore, it has been suggested that, in 
T cells, IKK1 and IKK2 are recruited to the lipid rafts at 
the immune synapse upon TCR activation［6］, therefore 
I first examined the recruitment of IKK2 into the lipid 
Fig. 7 IKK2 is recruited to the lipid rafts upon FcɛRI 
stimulation.
　Localization of IKK2, SNAP-23, Syntaxin 4, and 
VAMP-2 in lipid raft upon FceRI stimulation. Cell lysates 
of unstimulated or stimulated RBL-2H3 cells were 
fractionated by sucrose density gradient ultracentrifugation 
and blotted with each Ab. CTx blotting indicates that 
fraction #5 contains lipid raft. （ref.3）
Fig. 8 IKK2 associates with SNAP-23 upon FcɛRI 
stimulation.
　IKK2 associates with SNAP-23 in the lipid raft 
fractions only after FcɛRI-stimulation. Lipid raft fraction 
isolated from unstimulated or stimulated RBL-2H3 cells 
were subjected to immunoprecipitations （IP） with anti-
SNAP-23 antibody. Immunoprecipitants were blotted with 
each Ab. （ref.3）
Fig. 9 IKK2 phosphorylates SNAP-23 on Ser120 and 
Ser95.
　（A） Equal amounts of purified wild type and mutant 
GST-SNAP-23 proteins were incubated with ［γ-32P］
ATP and IKK2 and the reaction was analyzed by SDS-
PAGE and PhosphorImager analysis. （B） IgE-induced 
phosphorylation of SNAP-23 on Ser120 and Ser95 is 
impaired in IKK2-/- mast cells. WT or IKK2-/- mast 
cells were cross-linked upon FceRI. Fifteen minutes later, 
cell lysates were recovered and analyzed by immunoblot 
analysis using phosphorylation site specific antibodies. 
（ref.3）
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Concluding remarks
 In addition to critical roles of IKK2 in NF-κB- 
mediated biological responses, my data has identified 
novel NF-κB-independent roles of IKK2 in mast cell 
degranulation. A thorough characterization of IKK2 in 
in vitro. To assess whether this phosphorylation by IKK2 
occurs in vivo, we used phospho-specific antibodies. 
Ser 120 and Ser95 were phosophorylated upon FcɛRI 
stimulation in wild type （Fig. 9B）. In contrast, little or 
no phosphorylation was detected in IKK2-/- FLMCs 
（Fig. 9B）. These results show that SNAP-23 is 
phosphorylated by IKK2 at Ser120 and Ser95 in vitro 
and in vivo and that IgE-induced phosphorylation of 
SNAP-23 requires IKK2. 
ｆ） Phosphorylation of SNAP-23 is crucial for 
IKK2-mediated-degranulation
 Finally, to examine the effect of expression of 
phospho-mimetic mutant of SNAP-23, which can 
function without serine phosphorylation, in IKK2-/- 
mast cells on FcɛRI-stimulated β-hexosaminidase 
release and in vivo PCA reactions, phospho-mimetic 
mutant SNAP23EE by mutating serines 95 and 120 
was generated. Retroviral transduction of WT SNAP-
23 did not rescue the impairment of FcɛRI-induced 
β-hexosaminidase release in IKK2-/- mast cells 
（Fig. 10A）. By contrast, expression of SNAP-23EE 
partially rescued the impairment of FcɛRI-induced 
degranulation in IKK2-/- mast cells （Fig. 10A）. I also 
examined in vivo early phase PCA reactions in mast 
cell-reconstituted W/Wv mice. Mice with WT SNAP-
23 or mock transduced IKK2-/- FLMCs exhibited 
similar levels of reduced cutaneous anaphylaxis （Fig. 
10B）, in comparison with mice with control WT 
FLMCs, as assessed by change in ear thickness 1 hour 
after antigen challenge. By contrast, mice with SNAP-
23EE transduced IKK2-/- FLMCs exhibited increased 
cutaneous anaphylaxis than mice with mock transduced 
IKK2-/- FLMCs （Fig. 10B）. These results suggest 
that lack of phosphorylation of SNAP-23 on Ser120 
and ser95 is responsible for the impairment of FcɛRI-
induced degranulation in IKK2-/- mast cells. Taken 
together, these results indicate that IKK2-induced 
SNAP-23 phosphorylation is a key event in SNARE 
complex formation leading to IgE-induced degranulation 
in mast cells （Fig. 11）.
Fig. 10 Phosphorylation of SNAP-23 on Ser120 
and Ser95  involved in IKK2-mediated-
degranulation.
　（A） Expression of phospho-mimetic mutant of SNAP-
23 partially rescue the impairment of FceRI-induced 
β-hexosaminidase release in IKK2-/- mast cells. Mast 
cells were infected with retroviruses of pMX-puro-FLAG-
WT SANP-23, pMX-puro-FLAG-SNAP-23EE, or pMX-
puro （Mock）. Cells were cross-linked upon FcɛRI. 
Thirty minutes later, β-hexosaminidase activity in the 
supernatants and lysates of the cell pelletes was quantified. 
*P＜0.01. NS, not significant. （B） For passive cutaneous 
anaphylaxis, mock vector transduced WT mast cells, and 
mock vector, WT SNAP-23, or SNAP-23EE transduced 
IKK2-/- mast cells, were injected intradermally into the 
right ear of W/Wv mice. Four weeks later, PCA were 
induced in these mice. *P＜0.01. NS, not significant. 
（ref.3）
Fig. 11 IKK2 plays critical roles in mast cell degranu-
lation.
　IKK2-induced SNAP-23 phosphorylation is a key event 
in SNARE complex formation leading to IgE-induced 
degranulation in mast cells.
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mast cell degranulation will provide new insights into 
the pathogenesis of mast cell-mediated allergic diseases 
such as asthma, allergic rhinitis, and atopic dermatitis. I 
have already demonstrated that IKK2-selective inhibitors 
repress mast cell degranulation, suggesting that IKK2-
selective inhibitors have a therapeutic potential for 
allergic diseases. 
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